125 related articles for article (PubMed ID: 15127718)
1. Delivering on immunosuppression.
Dell H
Drug Discov Today; 2004 Apr; 9(8):345. PubMed ID: 15127718
[No Abstract] [Full Text] [Related]
2. On the way to a better immunosuppressant?
Hagmann M
Science; 1999 Sep; 285(5436):2042. PubMed ID: 10523192
[No Abstract] [Full Text] [Related]
3. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice.
Noguchi H; Matsushita M; Okitsu T; Moriwaki A; Tomizawa K; Kang S; Li ST; Kobayashi N; Matsumoto S; Tanaka K; Tanaka N; Matsui H
Nat Med; 2004 Mar; 10(3):305-9. PubMed ID: 14770176
[TBL] [Abstract][Full Text] [Related]
4. Manipulating immune responses with immunosuppressive agents that target NFAT.
Kiani A; Rao A; Aramburu J
Immunity; 2000 Apr; 12(4):359-72. PubMed ID: 10795734
[No Abstract] [Full Text] [Related]
5. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
[No Abstract] [Full Text] [Related]
6. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
[TBL] [Abstract][Full Text] [Related]
7. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
Tamura K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
[No Abstract] [Full Text] [Related]
8. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.
Crabtree GR
Cell; 1999 Mar; 96(5):611-4. PubMed ID: 10089876
[No Abstract] [Full Text] [Related]
9. Inhibitors of the calcineurin/NFAT pathway.
Martínez-Martínez S; Redondo JM
Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
[TBL] [Abstract][Full Text] [Related]
10. Acceptance of intrahepatic islet allografts without immunosuppression in the limited strain combination of mice from C57BL/6 to BALB/c.
Nagai T; Yasunami Y; Ikehara Y; Kodama S; Maki T; Ikeda S
Transplant Proc; 1998 Mar; 30(2):418. PubMed ID: 9532107
[No Abstract] [Full Text] [Related]
11. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression.
Venkatesh N; Feng Y; DeDecker B; Yacono P; Golan D; Mitchison T; McKeon F
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8969-74. PubMed ID: 15184684
[TBL] [Abstract][Full Text] [Related]
12. A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection.
Waegell W; Babineau M; Hart M; Dixon K; McRae B; Wallace C; Leach M; Ratnofsky S; Belanger A; Hirst G; Rossini A; Appel M; Mordes J; Greiner D; Banerjee S
Transplant Proc; 2002 Aug; 34(5):1411-7. PubMed ID: 12176420
[No Abstract] [Full Text] [Related]
13. Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway.
Murphy LL; Hughes CC
J Immunol; 2002 Oct; 169(7):3717-25. PubMed ID: 12244165
[TBL] [Abstract][Full Text] [Related]
14. Transplantation tolerance by 1,25-dihydroxyvitamin D(3)-induced costimulation blockade.
Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli A; Adorini L
Transplant Proc; 2001; 33(1-2):219-20. PubMed ID: 11266786
[No Abstract] [Full Text] [Related]
15. The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial.
Sommerer C; Schaier M; Morath C; Schwenger V; Rauch G; Giese T; Zeier M
Trials; 2014 Dec; 15():489. PubMed ID: 25494823
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide. Arava, HWA 486, SU 101.
Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
[No Abstract] [Full Text] [Related]
18. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
[No Abstract] [Full Text] [Related]
19. Leflunomide-based immunosuppression for porcine islet xenotransplantation.
Mital D; Guo Z; Tian Y; Shen J; Podlasek W; Foster P; Sankary H; Jensik S; McChesney L; Chong A; Olack B; Williams J
Transplant Proc; 1998 Mar; 30(2):515. PubMed ID: 9532154
[No Abstract] [Full Text] [Related]
20. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
